Diversified Healthcare Trust
NASDAQ:DHCREIT - Healthcare Facilities
+$0.25 today
- Market cap
- $1.76B
- Beta
- 2.29
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$1.33
- Dividend yield
- 0.45%
Volume 1.69M
Average 1.79M
DHC Debt Repayment
Cash used to repay borrowings during the period.
Diversified Healthcare TrustNASDAQ: DHC
Debt Repayment · Q1 FY2026 · quarter ended Mar 2026
Debt repayment dips below year-ago levels
Q1 FY2026 debt repayment of $1.19M (cash outflow) fell 98.8% year over year, behind the +217.4% change in trailing-twelve-month debt repayment. Sequentially, it fell 99.6% from the prior quarter. Over 3 fiscal years it compounded at -11.5% a year.
Context
- Debt repayment amounted to 28.8% of revenue in FY2025, up 28.6 pp from a year earlier.
- Debt repayment grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -98.8% toward the trailing-twelve-month pace of +217.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Debt Repayment history
USD · from the cash flow
- Latest · FY2025
- (443.54M) USD
- Year-over-year change
- -13683.1%
| Period | Period end | Debt Repayment | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (443.54M) | -13683.1% |
| FY2024 | 2024-12-31 | (3.22M) | +98.5% |
| FY2023 | 2023-12-31 | (217.05M) | +66.0% |
| FY2022 | 2022-12-31 | (639.07M) | -181.0% |
| FY2021 | 2021-12-31 | 789.34M | — |
Debt Repayment vs competitors
How DHC compares with its peers on the latest reported figures
- DHC's LTM Mar 2026 debt repayment of $323.1M is the 4th largest of the 7 companies compared; the peer median is $14.63M.
- Its year-over-year change of +217.4% is the 3rd highest of 7, against a peer median of +28.4%.
- Debt repayment amounts to 21.3% of revenue for DHC, versus a peer median of 48.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $6.56B | +316.9% | +119.6% | 467.0% | |
| LTM Mar 2026 | $1.7B | +135.5% | -68.6% | 222.2% | |
| LTM Mar 2026 | $731.01M | -1241.6% | — | 89.8% | |
| LTM Mar 2026 | $323.1M | +217.4% | -11.5% | 21.3% | |
| LTM Mar 2026 | $50.8M | -91.7% | +13.4% | 7.1% | |
| LTM Mar 2026 | $24M | -78.6% | -24.8% | 4.2% | |
| LTM Mar 2026 | $5.26M | +283.8% | -53.6% | 1.9% | |
| Peer median (excluding DHC) | $14.63M | +28.4% | -24.8% | 48.4% | |
Competitors are the stored peer set for DHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 179.93M | (15.77M) | (293.57M) | (370.26M) | (285.89M) |
| Depreciation & Amortization | 263.92M | 239.53M | 283.84M | 285.06M | 262.04M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | (65.12M) | 1.64M | (27.84M) | 6.82M | 33.26M |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | (65.12M) | 1.64M | (27.84M) | 6.82M | 33.26M |
| Other Non-Cash Items | (442.05M) | (265.74M) | 48.05M | 190.6M | (29.03M) |
| Operating Cash Flow | (63.32M) | (40.35M) | 10.48M | 112.22M | (19.62M) |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Acquisitions (Net) | 367.03M | 108.42M | 0 | (21.18M) | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (124.34M) | 279.28M | (202.11M) | (165.84M) | 483.57M |
| Investing Cash Flow | 242.7M | 387.71M | (202.11M) | (187.02M) | 483.57M |
| Debt Repayment | 789.34M | (639.07M) | (217.05M) | (3.22M) | (443.54M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (383K) | (171K) | (393K) | (904K) | (1.15M) |
| Dividends Paid | (9.54M) | (9.57M) | (9.6M) | (9.63M) | (9.66M) |
| Other Financing Activities | (32.7M) | (27.19M) | (22.68M) | (8.56M) | (37.66M) |
| Financing Cash Flow | 746.72M | (676M) | (249.71M) | (22.31M) | (492.01M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 926.1M | (328.64M) | (441.34M) | (97.11M) | (28.06M) |
| Free Cash Flow | (63.32M) | (40.35M) | 10.48M | 112.22M | (19.62M) |
Diversified Healthcare Trust
NASDAQ:DHC
Intrinsic Alpha fair value
Locked
Current Price
$7.24
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.